NGL Fine-Chem Limited manufactures and sells pharmaceuticals and intermediates for use in veterinary and human health worldwide. It offers active pharmaceutical ingredients, such as diminazene aceturate, diminazene diaceturate, homidium chloride, nitroxynil, clorsulon, parvaquone, buparvaquone, isometamidium chloride hydrochloride, toldimfos sodium, butaphosphan, imidocarb dipropionate, triclabendazole, ractopamine HCl, S-methoprene, praziquantel, toltrazuril, decoquinate, flunixin meglumine, carprofen, fenbendazole, amitraz, and marbofloxacin for animal health applications; and nitazoxanide, atovaquone, and ranolazine for human health applications. The company also provides various intermediate products; and finished dosage forms in granules and tablets. NGL Fine-Chem Limited was incorporated in 1981 and is based in Mumbai, India.

Ms. Pallavi  Pednekar

Company Secretary & Compliance Officer

Mr. Rahul Jayant Nachane

Όνομα	Κεφαλαιοποίηση αγοράς
Marksans Pharma Limited	0M
Luye Pharma Group Ltd.	0M
PT Kalbe Farma Tbk.	0M
Virbac SA	0M
Daiichi Sankyo Company, Limited	0M
Astellas Pharma Inc.	0M
Bristol-Myers Squibb Company	0M
Orion Oyj	0M
Chugai Pharmaceutical Co., Ltd.	0M
Novartis AG	0M

NGL Fine-Chem Limited

NGL Fine-Chem LimitedΛίστα ανταγωνιστών

Κύριοι ανταγωνιστές